Carbamazepine NDC 60687-479

NDC codes

FDA NDC Directory

Product NDC (as listed)60687-479Labeler and product segments. Claims need a package NDC.

Product NDC at billing width60687-0479Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
60687-479-01	60687047901	100 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-479-01) / 1 TABLET, CHEWABLE in 1 BLISTER PACK (60687-479-11)Marketed from Jan 3, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Carbamazepine
Generic name (nonproprietary): carbamazepine
Active ingredients: Carbamazepine — 100 mg/1
Dosage form: Tablet, Chewable
Route: Oral
Labeler: American Health Packaging
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 075712
Marketing start: Jan 3, 2020
Listing expires: Dec 31, 2026
Other FDA classes: Cytochrome P450 1A2 Inducers (Mechanism)Cytochrome P450 2B6 Inducers (Mechanism)Cytochrome P450 2C19 Inducers (Mechanism)Cytochrome P450 2C9 Inducers (Mechanism)Cytochrome P450 3A4 Inducers (Mechanism)Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
Identifiers: Product ID 60687-479_45383876-8944-0ac1-e063-6294a90a861dSPL ID 45383876-8944-0ac1-e063-6294a90a861dSPL set ID f8444c23-a74f-4d44-867e-26554dbb882fRxCUI 308973UNII 33CM23913M
Pharmacologic class: Mood Stabilizer

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N460687047901 followed by a unit qualifier and the quantity

Package 60687-0479-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 5, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Epilepsy Carbamazepine is indicated for use as an anticonvulsant drug. Evidence supporting efficacy of carbamazepine as an anticonvulsant was derived from active drug-controlled studies that enrolled patients with the following seizure types: Partial seizures with complex symptomatology (psychomotor, temporal lobe). Patients with these seizures appear to show greater improvement than those with other types. Generalized tonic-clonic seizures (grand mal). Mixed seizure patterns which include the above, or other partial or generalized seizures. Absence seizures (petit mal) do not appear to be controlled by carbamazepine (see PRECAUTIONS, General ). Trigeminal Neuralgia Car…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 075712

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 075712
Product	Strength	Form · route	Labeler	Product NDC
Carbamazepine	Carbamazepine 100 mg/1	Tablet, ChewableOral	Torrent Pharmaceuticals Limited	13668-271
Carbamazepine	Carbamazepine 100 mg/1	Tablet, ChewableOral	Coupler LLC	67046-0753
Carbamazepine	Carbamazepine 100 mg/1	Tablet, ChewableOral	Bryant Ranch Prepack	72162-2572
Carbamazepine	Carbamazepine 100 mg/1	Tablet, ChewableOral	Major Pharmaceuticals	0904-3854